-
公开(公告)号:US5589489A
公开(公告)日:1996-12-31
申请号:US353767
申请日:1994-12-12
申请人: Ashokkumar B. Shenvi , Robert T. Jacobs , Scott C. Miller , Cyrus J. Ohnmacht, Jr. , Chris A. Veale
发明人: Ashokkumar B. Shenvi , Robert T. Jacobs , Scott C. Miller , Cyrus J. Ohnmacht, Jr. , Chris A. Veale
IPC分类号: A61K31/40 , A61P11/00 , C07D401/06 , C07D401/14 , A61K31/445
CPC分类号: C07D401/06 , C07D401/14
摘要: Compounds of formula I ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, and Q.sup.4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
摘要翻译: 式I的化合物其中Q1,Q2,Q3和Q4具有本说明书中给出的任何含义,其N-氧化物及其药学上可接受的盐是神经激肽A的非肽拮抗剂,可用于治疗 哮喘等。还公开了药物组合物,制备式I化合物的方法和中间体。
-
公开(公告)号:US5635509A
公开(公告)日:1997-06-03
申请号:US432309
申请日:1995-05-01
申请人: Robert T. Jacobs , Scott C. Miller , Ashokkumar B. Shenvi , Cyrus J. Ohnmacht, Jr. , Chris A. Veale
发明人: Robert T. Jacobs , Scott C. Miller , Ashokkumar B. Shenvi , Cyrus J. Ohnmacht, Jr. , Chris A. Veale
IPC分类号: A61K31/4427 , A61K31/445 , A61K31/505 , A61P11/00 , A61P11/06 , A61P43/00 , C07D401/06 , C07D401/14 , C07D239/10
CPC分类号: C07D401/06 , C07D401/14
摘要: Compounds of formula I ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, and Q.sup.4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
摘要翻译: 式I的化合物其中Q1,Q2,Q3和Q4具有本说明书中给出的任何含义,其N-氧化物及其药学上可接受的盐是神经激肽A的非肽拮抗剂,可用于治疗 哮喘等。还公开了药物组合物,制备式I化合物的方法和中间体。
-
公开(公告)号:US5455253A
公开(公告)日:1995-10-03
申请号:US227833
申请日:1994-04-14
IPC分类号: C07D215/20 , C07D215/54 , C07D219/06 , C07D405/04 , A61K31/435
CPC分类号: C07D405/04 , C07D215/20 , C07D215/54 , C07D219/06
摘要: Compounds of formula I ##STR1## wherein R.sup.2, R.sup.3, R.sup.4, R.sup.10 and R.sup.11 have any of the meanings given in the specification, and their pharmaceutically acceptable salts are useful in the treatment of urinery incontinence. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.
摘要翻译: 式I的化合物其中R2,R3,R4,R10和R11具有本说明书中给出的任何含义及其药学上可接受的盐可用于治疗尿失禁。 还公开了药物组合物,制备式I化合物和中间体的方法。
-
公开(公告)号:US5622964A
公开(公告)日:1997-04-22
申请号:US516713
申请日:1995-08-18
IPC分类号: C07D215/20 , C07D215/54 , C07D219/06 , C07D405/04 , A61K31/435
CPC分类号: C07D405/04 , C07D215/20 , C07D215/54 , C07D219/06
摘要: Methods of treating asthma are provided which methods comprise administering to a mammal in need of such treatment an effective amount of a compound of Formula I ##STR1## or a pharmaceutically acceptable salt thereof wherein R.sup.2, R.sup.3, R.sup.4, R.sup.10 and R.sup.11 have any of the meanings given in the specification.
摘要翻译: 提供治疗哮喘的方法,所述方法包括向需要这种治疗的哺乳动物施用有效量的式I化合物或其药学上可接受的盐,其中R 2,R 3,R 4,R 10和R 11具有 说明书中给出的含义。
-
-
-